FDA approves two new technetium-labeled cardiac agents and a pharmacologic alternative to exercise in stress-thallium studies.
Ghosh
P R
PR
D003327:Coronary Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging; D004176:Dipyridamole; D006801:Humans; D015609:Organotechnetium Compounds; D010091:Oximes; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi
D015609:Organotechnetium Compounds; D010091:Oximes; D004176:Dipyridamole; D017256:Technetium Tc 99m Sestamibi; C060156:technetium Tc 99m teboroxime